Cargando…

Establishment of the South Korean national antimicrobial resistance surveillance system, Kor-GLASS, in 2016

Surveillance plays a pivotal role in overcoming antimicrobial resistance (AMR) in bacterial pathogens, and a variety of surveillance systems have been set up and employed in many countries. In 2015, the World Health Organization launched the Global Antimicrobial Resistance Surveillance System (GLASS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyukmin, Yoon, Eun-Jeong, Kim, Dokyun, Jeong, Seok Hoon, Shin, Jong Hee, Shin, Jeong Hwan, Shin, Kyeong Seob, Kim, Young Ah, Uh, Young, Park, Chan, Lee, Kwang Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199867/
https://www.ncbi.nlm.nih.gov/pubmed/30352643
http://dx.doi.org/10.2807/1560-7917.ES.2018.23.42.1700734
Descripción
Sumario:Surveillance plays a pivotal role in overcoming antimicrobial resistance (AMR) in bacterial pathogens, and a variety of surveillance systems have been set up and employed in many countries. In 2015, the World Health Organization launched the Global Antimicrobial Resistance Surveillance System (GLASS) as a part of the global action plan to enhance national and global surveillance and research. The aims of GLASS are to foster development of national surveillance systems and to enable collection, analysis and sharing of standardised, comparable and validated data on AMR between different countries. The South Korean AMR surveillance system, Kor-GLASS, is compatible with the GLASS platform and was established in 2016 and based on the principles of representativeness, specialisation, harmonisation and localisation. In this report, we summarise principles and processes in order to share our experiences with other countries planning to establish a national AMR surveillance system. The pilot operation of Kor-GLASS allowed us to understand the national burden of specific infectious diseases and the status of bacterial AMR. Issues pertaining to high costs and labour-intensive operation were raised during the pilot, and improvements are being made.